% Expired Patents = 16.7

EPO Patents = 3

Forward Citations = 2

Loading Chart...

25 inventors (with patents filed for the assignee):

Gilles Favre (3 out of 7 patents)

Aurelien Olichon (2 out of 5 patents)

Laura Keller (2 out of 2 patents)

4. Nicolas Bery (2 out of 2 patents)

5. Patrick Chinestra (2 out of 2 patents)

6. Philippe Rochaix (2 out of 2 patents)

7. Mary Poupot (1 out of 2 patents)

8. Loïc Ysebaert (1 out of 1 patent)

9. Marie Tosolini (1 out of 1 patent)

10. Pierre Brousset (1 out of 1 patent)

11. Thierry Levade (1 out of 5 patents)

12. Bruno Segui (1 out of 5 patents)

13. Florie Bertrand (1 out of 3 patents)

14. Julia Rochotte (1 out of 2 patents)

15. Nathalie Andrieu-Abadie (1 out of 4 patents)

6 patents: Sort by Forward Citations

1. 12740979 - Methods for the treatment of cancers that have acquired resistance to kinase inhibitors (2026-09-22),

2. 11319381 - Anti-rho GTPase conformational single domain antibodies and uses thereof (2022-05-03),

3. 11186634 - Antibodies targeting tumor associated macrophages and uses thereof (2021-11-30),

4. 10544210 - Anti-Rho GTPase conformational single domain antibodies and uses thereof (2020-01-28),

5. 10144772 - Method for treating melanoma (2018-12-04),

6. 8865408 - Signature for the diagnosis of cancer aggressiveness and genetic instability (2014-10-21),

Institut Claudius Regaud is a leading cancer research and treatment center in France. It offers state-of-the-art medical care and conducts cutting-edge research in oncology. The institute is dedicated to providing personalized treatment plans for each patient and improving outcomes through innovative therapies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

6 Patents

#21 in Toulouse

#2,485 in France

Toulouse, France

Institut Claudius Regaud